SCORE

63

RGEN: Repligen Corporation is a Buy


The current rating for RGEN is 63, which is 26% above its historic median rating of 50. This indicates lower risk than normal.


The rating is currently showing a higher than normal reading, suggesting risk levels could be lower than normal.